Literature DB >> 6434122

Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.

S G Allan, M A Cornbleet, P S Warrington, I M Golland, R C Leonard, J N Smyth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434122      PMCID: PMC1443393          DOI: 10.1136/bmj.289.6449.878-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  High-dose metoclopramide in cancer chemotherapy-induced nausea and vomiting.

Authors:  N B Bui; G Marit; B Hoerni
Journal:  Cancer Treat Rep       Date:  1982-12

2.  High-dose dexamethasone for prevention of cis-platin-induced vomiting.

Authors:  M S Aapro; D S Alberts
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy.

Authors:  P A Cassileth; E J Lusk; S Torri; N DiNubile; S L Gerson
Journal:  Arch Intern Med       Date:  1983-07

4.  Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide.

Authors:  E D Bruera; E Roca; L Cedaro; R Chacón; R Estévez
Journal:  Cancer Treat Rep       Date:  1983-04

5.  Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.

Authors:  R J Gralla; L M Itri; S E Pisko; A E Squillante; D P Kelsen; D W Braun; L A Bordin; T J Braun; C W Young
Journal:  N Engl J Med       Date:  1981-10-15       Impact factor: 91.245

  5 in total
  20 in total

Review 1.  Standard treatment of chemotherapy-induced emesis.

Authors:  D Warr
Journal:  Support Care Cancer       Date:  1997-01       Impact factor: 3.603

Review 2.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 3.  Antiemetics in cancer chemotherapy: historical perspective and current state of the art.

Authors:  M Tonato; F Roila; A Del Favero; E Ballatori
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603

Review 4.  Delayed emesis: a dilemma in antiemetic control.

Authors:  R A Clark; R J Gralla
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

Review 5.  Progress in controlling emesis with cancer chemotherapy.

Authors:  R J Gralla; R A Clark
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

6.  Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapy.

Authors:  S C Grant; M G Kris; R J Gralla; R A Clark; L B Tyson
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting--the Nordic experience.

Authors:  B Sorbe; H Andersson; M Schmidt; M Söderberg; T Högberg; L Wernstedt; E T Janson; B Ehrnström; M Kjaer; H Havsteen
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

8.  Single-dose i.v. dexamethasone--an effective anti-emetic in cancer chemotherapy.

Authors:  H Parry; K Martin
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

9.  Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam.

Authors:  M C Palmer; B M Colls
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Glucocorticoids attenuate taste aversions produced by toxins in rats.

Authors:  S Revusky; G M Martin
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.